A carregar...
Point-of-care testing of coagulation in patients treated with edoxaban
Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...
Na minha lista:
| Publicado no: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515947/ https://ncbi.nlm.nih.gov/pubmed/32436010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02143-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|